methylselenic acid has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Turovsky, EA; Varlamova, EG | 1 |
| Andresen, L; Hagemann-Jensen, M; Kehlet, S; Pastorekova, S; Skov, S; Uhlenbrock, F | 1 |
| Cheng, WH; Kang, MM; Schoene, NW; Wu, M | 1 |
| Brumaghim, JL; Ramoutar, RR | 1 |
| Azrak, RG; Rempinski, DR; Rustum, YM; Saifo, MS | 1 |
| Dong, Y; Fan, L; Hu, H; Li, J; Lu, J; Vang, O; Wang, L; Yin, S | 1 |
| Abdulah, R; Koyama, H; Miyazaki, K; Nakazawa, M | 1 |
3 review(s) available for methylselenic acid and Neoplasms
| Article | Year |
|---|---|
THE MAIN CYTOTOXIC EFFECTS OF METHYLSELENINIC ACID ON VARIOUS CANCER CELLS.
Topics: Animals; Carcinogenesis; Cytotoxins; Endoplasmic Reticulum Stress; Humans; Neoplasms; Organoselenium Compounds; Selenoproteins | 2021 |
Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds.
Topics: Animals; Anticarcinogenic Agents; Antioxidants; Cell Death; Dimethyl Sulfoxide; Disulfides; Humans; Methionine; Neoplasms; Organoselenium Compounds; Oxidants; Reactive Oxygen Species; Selenium; Sulfinic Acids; Sulfones; Sulfur | 2010 |
Chemical forms of selenium for cancer prevention.
Topics: Anticarcinogenic Agents; Chromatography; Chromatography, High Pressure Liquid; Cysteine; Food; Glutathione Peroxidase; Humans; Iodide Peroxidase; Mass Spectrometry; Methionine Sulfoxide Reductases; Models, Chemical; Neoplasms; Organoselenium Compounds; Selenium; Selenocysteine; Selenoprotein P; Selenoprotein W; Thioredoxin-Disulfide Reductase | 2005 |
4 other study(ies) available for methylselenic acid and Neoplasms
| Article | Year |
|---|---|
The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway.
Topics: Antigens, Differentiation, B-Lymphocyte; Antigens, Surface; Biological Transport; Carbazoles; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Depsipeptides; Endosomes; Enzyme Inhibitors; GPI-Linked Proteins; HEK293 Cells; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intercellular Signaling Peptides and Proteins; Jurkat Cells; Lymphocyte Activation; Melanoma; Neoplasms; Organoselenium Compounds; Protein Kinase C; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcription, Genetic; Vorinostat | 2014 |
Selenium compounds activate early barriers of tumorigenesis.
Topics: Anticarcinogenic Agents; Antioxidants; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cellular Senescence; Cysteine; DNA Damage; DNA Repair; DNA-Binding Proteins; Histones; Humans; Male; Neoplasms; Organoselenium Compounds; Oxidative Stress; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Selenium Compounds; Selenocysteine; Sodium Selenite; Tumor Suppressor Proteins | 2010 |
Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers.
Topics: Antineoplastic Agents; beta Catenin; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Neoplasms; Organoplatinum Compounds; Organoselenium Compounds; Oxaliplatin; Paclitaxel; RNA Interference; Taxoids; Topotecan | 2010 |
Methylseleninic acid potentiates multiple types of cancer cells to ABT-737-induced apoptosis by targeting Mcl-1 and Bad.
Topics: Apoptosis; bcl-Associated Death Protein; Biphenyl Compounds; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Nitrophenols; Organoselenium Compounds; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides | 2012 |